These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8366760)

  • 1. Pharmacological characterization of Abbott-81282, a novel, non-peptide angiotensin-II antagonist selective for type-1 receptors.
    Hancock AA; Buckner SA; Lee JY; Brune M; Morse PA; Oheim K; Warner RB; Winn M; Zydowsky TM; De B
    Life Sci; 1993; 53(11):929-37. PubMed ID: 8366760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor interactions of Abbott-81988, a highly potent, non-peptide angiotensin-II antagonist selective for type-1 receptors.
    Hancock AA; Buckner SA; Lee JY; Brune M; Morse PA; Oheim K; Warner RB; Winn M; Zydowsky TM; De B
    J Recept Res; 1994 May; 14(3-4):229-49. PubMed ID: 8083867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
    Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
    Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist.
    Mochizuki S; Sato T; Furuta K; Hase K; Ohkura Y; Fukai C; Kosakai K; Wakabayashi S; Tomiyama A
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):22-9. PubMed ID: 7723348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and pharmacokinetic evaluation of EXP3312, an orally-active non-peptide angiotensin II-receptor antagonist.
    Wong YN; Wong PC
    J Pharm Pharmacol; 1996 May; 48(5):492-7. PubMed ID: 8799873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.
    Cazaubon C; Gougat J; Bousquet F; Guiraudou P; Gayraud R; Lacour C; Roccon A; Galindo G; Barthelemy G; Gautret B
    J Pharmacol Exp Ther; 1993 May; 265(2):826-34. PubMed ID: 8496828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
    Chang RS; Siegl PK; Clineschmidt BV; Mantlo NB; Chakravarty PK; Greenlee WJ; Patchett AA; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):133-8. PubMed ID: 1625192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpeptide angiotensin II receptor antagonist recognizes inter-species differences in angiotensin AT1 receptors.
    Kawano K; Fujishima K; Nagura J; Yasuda S; Shinki ; Hachisu M; Konno F
    Eur J Pharmacol; 1998 Sep; 357(1):33-9. PubMed ID: 9788771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EXP597, a nonpeptide angiotensin II receptor antagonist with high affinities for the angiotensin AT1 and AT2 receptor subtypes.
    Wong PC; Duncia JV; Santella JB; Smith RD; Wexler RR; Timmermans PB; Chiu AT
    Eur J Pharmacol; 1994 Aug; 260(2-3):261-4. PubMed ID: 7988654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]A-81988, a potent, selective, competitive antagonist radioligand for angiotensin AT1 receptors.
    Hancock AA; Surber BW; Rotert G; Thomas S; Tasker AS; Sorensen BK; Vodenlich AD; Opgenorth TJ; Kerkman DJ; DeBernardis JF
    Eur J Pharmacol; 1994 Mar; 267(1):49-54. PubMed ID: 8206129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiotensin AT(1) receptor antagonist irbesartan has near-peptide affinity and potently blocks receptor signaling.
    Hines J; Fluharty SJ; Sakai RR
    Eur J Pharmacol; 1999 Nov; 384(1):81-9. PubMed ID: 10611423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist.
    Nagura J; Yasuda S; Fujishima K; Yamamoto M; Hui C; Kawano K; Katano K; Ogino H; Hachisu M; Konno F
    Eur J Pharmacol; 1995 Feb; 274(1-3):201-11. PubMed ID: 7768273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that [Sar1]angiotensin II behaves differently from angiotensin II at angiotensin AT1 receptors in rabbit aorta.
    Liu YJ
    Eur J Pharmacol; 1993 Apr; 235(1):9-15. PubMed ID: 8519284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors.
    Chang RS; Lotti VJ; Chen TB; O'Malley SS; Bendesky RJ; Kling PJ; Kivlighn SD; Siegl PK; Ondeyka D; Greenlee WJ
    Eur J Pharmacol; 1995 Dec; 294(2-3):429-37. PubMed ID: 8750703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of BR-A-657, a highly potent nonpeptide angiotensin II receptor antagonist.
    Chi YH; Lee JH; Kim JH; Tan HK; Kim SL; Lee JY; Rim HK; Paik SH; Lee KT
    Biol Pharm Bull; 2013; 36(7):1208-15. PubMed ID: 23811571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.